The Diabetic Retinopathy Screening, Prevention and Control Program — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Diabetic Retinopathy Screening, Prevention and Control Program — Stella

Home/Diabetic Retinopathy/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Retinopathy trials

Trial locations(2 sites)

China

Ruijin hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, Shanghai Municipality

Shanghai Jiao-Tong University School of Medicine, Shanghai

Key details

Sponsor

Shanghai Jiao Tong University School of Medicine

Enrollment target

~500,000 participants

Started

June 2018

Primary completion

June 2038

Age range

18 Years and older

Last updated February 2020

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.